Teladoc Stock Claws Back Toward August Highs After Bull Note

Teladoc Health Inc (NYSE: TDOCis eyeing its third-straight jump today, up 1.2% at $226.94 in pre-market trading following a bull note from brokerage firm Berenberg. The analyst upgraded TDOC to a "buy" and lifted its price target to $252 from $157, citing the growing shift to telehealth, sparked by the pandemic. Berenberg added that Teladoc's acquisition of Livongo Health (LVGO) represents a compelling investment case.

Berenberg commended Teladoc's recent merger with Livongo Health, calling it a compelling investment case

Today's pop puts TDOC even closer to its Aug. 4 high of $253. While the shares saw a sharp pullback from this area not long after, the 110-day moving average created a springboard on the charts. During the past few weeks, the 60-day has also acted as a layer of support.

Should this positive price action continue, the brokerage bunch could start following Berenberg's lead. While the majority of the 24 analysts covering the stock called it a "buy" or better, coming into today, 10 still called TDOC a "hold." Plus, the 12-month consensus price target of $232.88 sat at just a slim 3.9% premium to last night's close. 

Short sellers, meanwhile, have been coming in in droves, with short interest surging an eyebrow-raising 78.5% in the last reporting period. This move has put these bears firmly in control. In fact, the 12.28 million shares sold short make up a healthy 17.2% of TDOC's available float, or a little less than four days of trading at the equity's average pace. 

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.